Clinical trials
Active, not recruiting Phase 2 Colorectal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
72 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 8 |
| 2020 | 7 |
| 2021 | 10 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 10 |
| 2025 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 72 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 7 |
| National Cancer Institute (NCI) | 5 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Seagen, a wholly owned subsidiary of Pfizer | 3 |
| Sun Yat-sen University | 3 |
| Blokhin's Russian Cancer Research Center | 2 |
| Fudan University | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Pfizer | 2 |
| University of Colorado, Denver | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 72 |
| Breast Neoplasms | 8 |
| Pancreatic Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Colonic Neoplasms | 5 |
| Neoplasms | 5 |
| Rectal Neoplasms | 5 |
| Lung Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Stomach Neoplasms | 4 |
Trials
Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.